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Background: Understanding the existence of a cycle, where psychological disturbances cause skin diseases and in turn, skin 
diseases cause psychological disorders, provides the basis for good dermatological practice. 
Objective: The aim of this case-control study is to examine the psychiatric morbidity of dermatological disorders in children 
and adolescents with no history of psychiatric disorders. 
Method: In this study, 502 participants (251 patients and 251 healthy individuals) were evaluated according to DSM-IV 
criteria. All participants were interviewed and evaluated using the Turkish version of the Kiddie Schedule for Affective 
Disorders and Schizophrenia – Present and Lifetime Version (K-SADS-PL) and the State-Trait Anxiety Inventory for Children 
(STAI-1 and STAI-2), the Childhood Depression Inventory (CDI), adolescent and parent forms of the Strengths and 
Difficulties Questionnaire (SDQ-A and SDQ-P) and a questionnaire evaluating child’s level of school success. 
Results: Our results indicated that the rates of general psychiatric comorbidity, mood disorders, anxiety disorders, and 
adjustment disorders were significantly higher in the study group compared to the control group. The CDI, STAI-1, STAI-2, 
and SDQ (and subscales) scores were significantly higher in the study group. Moreover, psychiatric comorbidity was higher 
in inflammatory and allergic dermatoses compared to other dermatological subgroups. Having a dermatological disease 
restricts physical activity thus increasing the risk of psychiatric comorbidity. 
Conclusions: Investigating the education, attitudes, and awareness of dermatologists about psychocutaneous disorders might 
contribute to the development of new educational strategies and elicit appropriate biopsychosocial approaches. 
 





Skin is a perfect protective coating with crucial 
functions somatic communication, sensory stimuli, 
and physical and emotional development (1, 2). The 
central nervous system and epidermis originate from 
the same embryological tissue and their interactions 
with each other in the later stages of life have become 
the subject of numerous studies (3). It is a prevalent 
opinion that in many cases psychological factors 
cause the dermatological disorders, or dermatological 
disorders are associated with certain personality 
traits, or dermatological disorders appear as a 
complication of psychiatric morbidity (4). Psychiatric 
comorbid diagnoses are estimated to be as high as 
30% in all dermatology patients (5). Compared to 
adult population, our knowledge in the area of the 
co-occurrence of the dermatological disorders with 
psychiatric morbidity in the pediatric age group and 
their effects on the clinical course and treatment 
process is limited.  
Studies show that in adolescence when secondary 
sexual characteristics start to develop, dermatological 
diseases may emerge concomitant with many 
psychiatric diseases, especially depression. While it is 
known that in children with dermatological 
disorders, information about the symptoms, triggers, 
and treatment is important, it has been shown that 
chronic dermatological disorders in particular can 





negatively affect the quality of life (6, 7). 
Dermatologists can play an important role in the 
management of psychocutaneous disorders because 
patients seek help from dermatology clinics for 
treatment of their skin problems but generally refuse 
psychiatric intervention. Undetected psycho-
pathology can greatly decrease a patient’s quality of 
life and even contribute significantly to the clinical 
severity of their skin disease. Therefore, a 
multidisciplinary approach is important for 
evaluating the patients from this point of view and to 
provide them with appropriate support (8). The aim 
of this study was to determine the sociodemographic 
and clinical characteristics affecting psychiatric 
comorbidity by examining pediatric patients that 
were treated in the dermatology outpatient clinic. 
 
Methods 
The study was approved by the local ethics 
committee (Ethics Committee of the Inonu 
University, Faculty of Medicine, 04.12.2013 and 
2013/163) and performed in accordance with the 
Declaration of Helsinki. Participants were assured of 
data confidentiality, and permission to use data for 
reports that ensured the protection of the 
participants’ identities were obtained from all 
participants through informed written consent to 
participate, and their parents consented to their and 
their children’s participation. 
 
Participants and procedures 
A total of 251 patients (6-18 years) who were treated 
in the Department of Dermatology Outpatient Clinic 
at Inonu University Faculty of Medicine between 
January 2014 and October 2015 were included in the 
study. All consecutive patients not suffering from 
chronic illness other than dermatological disorder, 
with no history of psychiatric disease were included. 
All patients in our study were under treatment for 
their dermatological condition or were not receiving 
new diagnosed treatment.  
The control group consisted of 251 individuals 
who did not have any dermatological disorders and 
had similar demographic characteristics as the study 
group. The healthy control group consisted of 
children who applied to the pediatric outpatient 
clinics of the university hospital for general 
examination. DSM-IV criteria, the K-SADS-PL, 
STAI-1 and STAI-2, CDI and SDQ-A and SDQ-P 
were used as psychiatric assessment scales. Child and 
adolescent psychiatrists practicing K-SADS-PL were 
blinded to the study group. 
 
Socio-demographic data form 
This form was developed by the research team to 
determine the socio-demographic characteristics, i.e. 
age, sex, school success, family type, living place of 
the parents and psychiatric/medical genealogical 
information. Also parents in charge of the children 
completed a questionnaire about their levels of 
school success. Parents were asked to classify every 
child’s level of school success as level I – very bad, 
level II – bad, level III – medium, level IV – good 
and level V – the best.   
 
Schedule for Affective Disorders and 
Schizophrenia for School Age Children-Present 
and Lifetime Version (K-SADS-PL) 
A semi-structured interview form developed by 
Kaufman et al. (9) was used to determine past and 
present psychopathologies of children and 
adolescents according to DSM-IV diagnostic criteria. 
Turkish adaptation, validity and reliability study of K-
SADS-PL-T was made by Gökler et al. (10). 
 
Children’s Depression Inventory (CDI) 
CDI detects the level of depression in children (11) 
and was developed by Kovacs in 1981. The validity 
and reliability of the Turkish CDI version was 
performed by Oy in 1991 (12). This scale consists of 
27 items. The score of each question varies between 
0 and 2. A score of 19 and above is considered 
pathological. 
 
State-Trait Anxiety Inventory (STAI-1 and STAI-
2) 
The inventory was developed by Spielberger et al. in 
1970, and has two subscales: state (STAI-1) and trait 
(STAI-2) (13). There are 40 items in total, 20 items in 
each scale. STAI-1 determines how the individual 
feels at a certain moment and under certain 
conditions. STAI-2 generally determines how the 
individual feels, regardless of the situation and 
circumstances. The answers are scored between 1 
and 4 on the 4-point Likert scale, and high scores 
indicate that the level of anxiety is high. The scale was 
adapted to Turkish by Öner and Le Compte in 1983 
(14). 
 
Strengths and Difficulties Questionnaire Forms 
(for parents and adolescents) 
The Strengths and Difficulties Questionnaire (SDQ) 
is a 25-item Likert-type questionnaire developed by 
Robert Goodman in 1997 for the purpose of 
questioning emotional and behavioral problems 
together with some favorable characteristics of 
children and adolescents aged 4–16 years (15). 
Questions on the scale are answered by parents, 
teachers, and adolescents as “not correct”, “partially 
correct,” and “absolutely correct” and scored “0”, 
“1,” and “2,” respectively. Questions 7, 11, 14, 21, 
and 25 of the scale are scored by reversing. 
It consists of five subscales related to emotional 
problems, conduct problems, and peer relationship 





problems. Forms of this questionnaire designed for 
4-16-year old individuals were to be responded by 
parents and teachers, and forms to be responded by 
11-16-year -old adolescents themselves can be 
completed within nearly 5 minutes. The adaptation 
of SDQ to Turkish language was realized by Guvenir 
et al. in 2008 (16). 
 
Statistical Analysis 
SPSS for Windows (version 17.0) was used for 
statistical analysis of the data. Descriptions of 
quantitative variables were expressed as mean (x) ± 
standard deviation (ss) and median (Min–Max), 
whereas qualitative data were expressed as numbers 
and percentages. 
Unpaired and paired t-tests were used to compare 
variables with normal distribution according to the 
Kolmogorov-Smirnov normality test. Variables that 
were not normally distributed were compared using 
Kruskal-Wallis analysis of variance, the Conover 
double comparison test, and the Mann-Whitney U 
test. Qualitative variables were tested with Pearson’s 
and Fisher’s chi-square tests; p < 0.05 was considered 
to be statistically significant. Sample size of the 
population was determined by setting the prevalence 
of psychiatric morbidity in the control group as 20% 
and based on our calculations, the sample size of 246 
was needed to detect a difference at 95% precision 
and alpha error of 0.05. We thus included 251 
patients in the study. 
 
Results 
A total of 502 children and adolescents were included 
in the study. Of the 251 children in the study group, 
93 (37.1%) were boys and 158 (62.9%) were girls; the 
control group consisted of 111 (44.2%) boys and 140 
(55.8%) girls (p = 0.102). The sociodemographic 
characteristics of both groups are shown in Table 1. 
The diagnoses in the study group included 55 
(21.9%) inflammatory dermatoses (psoriasis, lichen 
planus); 43 (17.1%) eczematous (seborrheic 
dermatitis, atopic dermatitis, hand eczema) and 
allergic dermatoses such as chronic urticarial; 42 
(16.7%) acneiform dermatoses (acne vulgaris, 
rosacea); 36 (14.3%) hair and nail disorders (telogen 
effluvium, alopecia areata, nail changes); 32 (12.7) 
chronic infectious dermatoses (bacterial, viral, 
parasitic, and fungal), 24 (9.6%) pigmentation 
disorders such as vitiligo; 3 (1.2%) genetic 
dermatoses (incontinentia pigmenti, epidermolysis 
bullosa); and 16 (6.4%) chronic cutaneous disorders 
like dermatitis herpetiformis and other 
acute/transient conditions such as insect bites and 
pruritus. The distribution of the diagnoses of 
dermatological diseases is shown in Table 2. 
The rates of general psychiatric comorbidity, mood 
disorders, anxiety disorders and adjustment disorders 
were significantly higher in the study group than in 
the control group (psychiatric comorbidity: 2 = 29.8, 
p = 0.0001; mood disorders: 2 = 11.14, p = 0.001; 
anxiety disorders: 2 = 11.54, p = 0.001; adjustment 
disorder: 2 = 30.77, p = 0.0001). There was no 
significant difference between the groups in terms of 
the other psychiatric disorders (Table 3).  
The CDI, STAI-1, STAI-2 and SDQ (and 
subscales) scores were significantly higher in the 
study group compared to the control group (Table 
4). 
Among the dermatological disease subgroups only 
inflammatory, eczematous and allergic dermatoses 
had significantly higher rate of comorbidity with 
psychiatric disorders (p = 0.016 for psychiatric 
disorder frequency in inflammatory dermatoses; p = 
0.037 for eczematous and allergic dermatoses) (Table 
5). In addition, we also found that having a 
dermatological disorder increased the risk of 
psychiatric comorbidity by limiting physical activity 













Male 93 (37.1) 111 (44.2) 
2.67 0.102 
Female 158 (62.9) 140 (55.8) 
Residential place 
City  182 (72.5) 226 (90) 
25.34 0.0001 
Rural Area (Village + Town) 69 (27.5) 25 (10) 
School success 
Successful 175 (72.9) 200 (81) 
4.46 0.035 
Struggling 65 (27.1) 47 (19) 
Family type 
Nuclear 184 (73.3) 214 (85.3) 
10.91 0.0001 
Extended 67 (26.7) 37 (14.7) 
Psychiatric disease history in the 
family 
Exists 30 (12) 23 (9.2) 
1.03 0.309 
Does not exist 221 (88) 228 (90.8) 
Togetherness with both parents 
Exists 229 (91.2) 232 (92.4) 
0.23 0.625 
Does not exist 22 (8.8) 19 (7.6) 
 X±SS X±SS t** p 
Age (6-18 years) 12.63±4.16 12.73±4.06 0.28 0.778 
Number of siblings 2.46±1.77  2.08±1.53  2.55 0.011 
Note. *Chi-square test, Chi-square value; ** Unpaired t test-value 






TABLE 2. Diagnostic distributions of dermatological diseases 
Dermatological disease     n % 
Inflammatory dermatoses 55 21.9 
Eczematous and allergic dermatoses 43 17.1 
Acneiform dermatoses 42 16.7 
Hair and nail disorders 36 14.3 
Chronic infectious dermatoses 32 12.7 
Pigmentation disorders 24 9.6 
Others (chronic cutaneous disorders) 10 4.0 
Others (acute/transient conditions) 6 2.4 
Genetic dermatoses 3 1.2 





TABLE 3. Comparison of psychiatric diagnosis distributions 





N (%) X2 p 
Psychiatric Disorder 
Exists 145 (57.8) 84 (33.5) 
29.8 0.0001 
Does not Exist 106 (42.2) 167 (66.5) 
ADHD 
Exists 57 (22.7) 49 (19.5) 
0.76 0.382 
Does not Exist 194 (77.3) 202 (80.5) 
Disruptive behavior disorders 
Exist 9 (3.6) 6 (2.4) 
0.61 0.432 
Do not exist 242 (96.4) 245 (97.6) 
Mood disorders 
Exist 35 (13.9) 13 (5.2) 
11.14 0.001 
Do not Exist 216 (86.1) 238 (94.8) 
Anxiety disorders 
Exist 37 (14.7) 14 (5.6) 
11.54 0.001 
Do not Exist 214 (85.3) 237 (94.4) 
Psychotic disorder 
Exists 1 (0.4) - 
1.00 0.317 
Does not Exist 250 (96.6) 251 (100) 
Speech disorder 
Exists 2 (0.8) 3 (1.2) 
0.20 0.653 
Does not Exist 249 (99.2) 248 (98.8) 
Tic disorders 
Exist 4 (1.6) 2 (0.8) 
0.67 0.411 
Do not Exist 247 (98.4) 249 (99.2) 
Adjustment disorder 
Exists 29 (11.6) - 
30.77 0.0001 
Does not Exist 222 (88.4) 251 (100) 
Elimination disorders 
Exist 13 (5.2) 11 (4.4) 
0.17 0.676 
Do not Exist 238 (94.8) 240 (95.6) 
Somatoform disorders 
Exist 1 (0.4) 1 (0.4) 
0.00 1.00 
Do not exist 250 (99.6) 250 (99.6) 
Trichotillomania 
Exists 1 (0.4) - 
1.00 0.317 
Does not Exist 250 (99.6) 251 (100) 
Tobacco use 
Exists 4 (1.6) 6 (2.4) 
0.40 0.523 
Does not Exist 247 (98.4) 245 (97.6) 
Sleep disorders 
Exist 4 (1.6) - 
4.03 0.124 
Do not Exist 247 (98.4) 251 (100) 












































No-psychiatric comorbidity  
(n=106) 
X2 p* 
Restrictedness in physical activity 26 (17.9) 7 (6.6) 6.88 0.009 
Chronicity 116 (80) 89 (84) 0.64 0.423 
Having a relapsing course 89 (61.4) 64 (60.4) 0.026 0.872 
Painfulness 10 (6.9) 11 (10.4) 0.96 0.325 
Itchiness 51 (35.2) 29 (27.4) 1.72 0.189 
Localization in visible place 94 (64.8) 66 (62.3) 0.17 0.676 
Being systemic 21 (14.5) 17 (16) 0.11 0.734 






In this study, we aimed to determine 
sociodemographic and clinical features that affect 
concomitant occurrence of dermatological diseases 
and psychiatric disorders in pediatric patients that 
were treated in a dermatology outpatient clinic. 
Analysis of the demographic distribution showed 
that a higher number of individuals in the control 
group lived in the city (Table 1). Although Kaplan et 
al. (1995) reported that living in a rural area may be a 
risk factor for depression, Erol et al.’s study (1998) 
conducted in Turkey showed that people living in 
cities had higher rates of depression (17, 18). 
Therefore, in our study, the effect of place of 










Depression 9 (0-39) 6 (0-35) 0.0001 
STAI-1 35 (20-71) 31(20-73) 0.0001 
STAI-2 45 (17-78) 41 (25-80) 0.0001 
SDQ-P 
Total difficulty score 11 (0-28) 9 (1-31) 0.0001 
Emotional problems 3 (0-10) 2 (0-9) 0.0001 
Behavior problems 2 (0-7) 1 (0-8) 0.001 
Attention and activity problems 4 (0-10) 3 (0-10) 0.002 
Peer problems 3 (0-10) 2 (0-8) 0.0001 
Social behaviors 8(1-10) 9 (2-10) 0.009 
SDQ-A 
Total difficulty score 11(1-29) 9 (0-30) 0.0001 
Emotional problems 3(0-10) 2 (0-10) 0.001 
Behavior problems 1(0-7) 1 (0-8) 0.039 
Attention and activity problems 4 (0-9) 3.5 (0-10) 0.007 
Peer problems 3 (0-10) 2 (0-8) 0.001 
Social behaviors 9 (2-10) 9 (1-10) 0.064 
Note. *Mann-Whitney’s U test 
 
TABLE 5. Psychiatric comorbidity frequency in dermatological disease sub-groups 






Inflammatory dermatoses 24 (16.6) 31(29.2) 5.76 0.016 
Eczematous and allergic dermatoses 31 (21.4) 12 (11.3) 4.36 0.037 
Acneiform dermatoses 25 (17.2) 17 (16.0) 0.06 0.801 
Hair and nail disorders 24 (16.6) 12 (11.3) 1.36 0.243 
Chronic infectious dermatoses 19 (13.1) 13 (12.3) 0.03 0.844 
Pigmentation disorders 13 (9.0) 11(10.4) 0.14 0.707 
Others (chronic cutaneous disorders) 7 (4.8) 5 (4.7) 0.63 0.525 
Others (acute/transient conditions) 1 (0.7) 5 (4.7) 4.25 0.086 
Genetic dermatoses 1 (0.7) 2 (1.9) 0.74 0.575 
Note. *Pearson Chi Square test  





residence on psychopathology can be interpreted as 
limited. The children’s school success levels in the 
questionnaire were determined by parents as level I – 
very bad, level II – bad, level III – medium, level IV 
– good and level V – the best. Levels 4 and 5 were 
grouped as successful, while levels 1, 2 and 3 were 
grouped as struggling. The school success rate of the 
study group was determined to be significantly lower 
than in the control group (Table 1). According to one 
study, school absenteeism (36.6%) and grade 
repetition (23.3%) constitute a significant problem in 
children with chronic illness, physical disability, and 
mental problems (19). Psychiatric disease history in 
the family was detected in 30 (12%) patients from the 
study group and in 23 (9.2 %) individuals in the 
control group (Table 1). 
When dermatological diseases were divided into 
groups, the most common diseases were 
inflammatory dermatoses, followed by eczematous 
and allergic dermatoses (Table 2). Among the studies 
made in Turkey, Tekin et al. investigated the 
prevalence of dermatological diseases in children 
living in Zonguldak and the surrounding area and 
found eczema to be the most common disease (20). 
We believe that this difference can be attributed to 
the fact the in the aforementioned study they 
investigated the distribution of dermatological 
diseases individually, whereas in our study we looked 
at the distribution of the diseases classified according 
to their broader diagnosis. In our study, the rate of 
children and adolescents diagnosed with any 
psychiatric disease was significantly higher in the 
study group than in the control group. Similarly, 
psychiatric diagnoses were found in approximately 
one quarter (25.2%) of the patients with 
dermatological disease in a study of psychiatric 
comorbidity with 2579 patients (21). In our study, the 
scores for mood disorders were significantly higher 
in the study group compared to the control group. 
Since data on the relationship between 
dermatological diseases and mood disorders in the 
pediatric age group are limited compared to data for 
adult patients, we believe that our study provides 
important information in that regard. In a study by 
Dornelles da Silva Manzoni et al. (2012), evaluating 
the life qualities of 118 children aged 5–16 years who 
were treated at the dermatology polyclinics in Brazil, 
the rates of shyness, low self-confidence, anxiety, and 
depressive mood were found to be higher compared 
to control (22). In another study, anxiety and 
depression were found to be the most common 
psychiatric problems associated with dermatological 
diseases. The common and visible characteristics of 
skin diseases are often associated with anxiety, 
depression and low self-esteem (23). In our study, 
anxiety disorders were significantly higher in the 
dermatological disorders group (Table 3). In an 
epidemiological study conducted in Turkey, it has 
been shown that anxiety disorders were the most 
frequently seen disorder (14.45%) in adolescents 
being treated in children’s psychiatry clinics (24). 
Moreover, in a study on dermatological diseases by 
Vargas et al., anxiety disorder was screened by 
separating the dermatology patients into subgroups 
(psoriasis, acute urticaria, atopic dermatitis, and 
others) and anxiety disorder was detected in 48% of 
the psoriasis group and 39% of the atopic dermatitis 
group (25). In our study, the diagnosis of adjustment 
disorder was found to be significantly higher in the 
study group. Studies have shown that children and 
adolescents had difficulty in adjusting to their new 
condition after the disease was diagnosed, however 
in time they adjusted to the disease and their initial 
low quality-of-life perceptions improved (26). In a 
medical record review study that covered 
dermatology patients, it was found that the most 
prevalent psychiatric diagnoses in the patients were 
depressive disorder and adjustment disorders (27). 
Similarly, in our study, adjustment disorder was 
determined in 29 (11.6%) of the patients in the study 
group, as opposed to none in the control group 
(Table 3). 
The CDI, STAI-1 and STAI-2 scores of the 
children in the study group were significantly higher 
compared to the control group (Table 4). These 
results indicate that the severity of both anxiety and 
depressive mood is higher in adolescents with 
dermatological disease than in healthy children. In 
one study, some adolescents with dermatological 
disease felt that they should be different by avoiding 
certain activities because they felt embarrassed about 
their appearance (28). Because adolescence is a 
special age with great physical and hormonal 
changes, it is also an important period for body image 
and self-presentation (29). 
The SDQ-P (and subscales) scores filled out by the 
parents of the children were higher in the study 
group, indicating that these patients experienced 
more behavioral and emotional difficulties compared 
to the control group. It is expected that children and 
adolescents with dermatological diseases will have 
more difficulties than their otherwise healthy 
counterparts and that their mechanisms to cope with 
these difficulties might be less efficient. 
The social behaviors subscale of the SDQ-P is a 
scale in which the current social strengths of the child 
and adolescent are questioned and evaluated. The 
higher the score, the lower the risk of psychiatric 
disorder. In our study, the evaluation of the SDQ-A 
and SDQ-P scores showed a significant difference 
between the study and control groups in all subscales 
except for the social behaviors subscale. This finding 
may be due to the fact that children and adolescents 





are not aware of their current strengths and 
mechanisms for dealing with problems. 
In our study, the incidence of psychiatric morbidity 
was found to be significantly higher in the 
inflammatory, eczematous and allergic dermatosis 
groups (Table 5). We believe that this increased rate 
is due to proinflammatory cytokines and some 
inflammatory processes being involved in the 
pathophysiology of depression and inflammatory 
diseases (30). Eczematous and allergic dermatosis 
groups may be intensively pruritic, or the 
angioedema may present with mild pain and burning 
sensation (31), symptoms that affect the patient’s 
quality of life significantly and may account for stress, 
negative self-image, disability in social functions and 
adverse emotions such as anger and depression (32-
34). 
In our study, we investigated the frequency of 
psychiatric morbidity in the clinical variables of 
pediatric age group with dermatological diseases. It 
has been determined that restricted physical activity 
related to dermatological disease is a significant risk 
factor for frequency of psychiatric disorders (Table 
6). One study has shown that the various clinical 
involvements associated with psoriasis have a direct 
effect on physical activity (35). In fact, physical 
limitation caused by dermatological disease decreases 
the quality of life and may result in emotional stress 
and psychiatric disease.  
 
Conclusion 
There is a real threat of psychiatric morbidity 
associated with dermatological disorders in the 
pediatric age group and if neglected this threat can 
negatively impact the children’s mental health and 
quality of life. We would like to emphasize the need 
for close collaboration between psychiatry and 




We believe that our study is a valuable addition to the 
literature because we focused on investigating 
psychiatric comorbidity in dermatological disorders 
in a child and adolescent population, which is an 
underrepresented study population. In addition, we 
used structured interview techniques and had a 
relatively large sample size and a control group that 
had matching sociodemographic characteristics. 
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